Beijing Tongkanghui Network Technology Co., Ltd announced that it has received $15,600,000 (CNY 99,968,000) in a equity round of funding from Guangdong Temei Health Technology Industry Co., Ltd. and returning investor Teyi Pharmaceutical Group Co.,Ltd and on November 2, 2021. The actual investment amount of Guangdong Temei Health Technology Industry Co., Ltd. and the allocation ratio of the capital increase will be subject to the investment agreement officially signed by the company. The estimated pre-money valuation is of approximately CNY 550 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.56 CNY | -3.28% | -5.83% | -33.12% |
04-19 | Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-29 | Teyi Pharmaceutical Group Co.,Ltd Approves the Cash Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.12% | 624M | |
+42.60% | 739B | |
+32.34% | 598B | |
-5.74% | 353B | |
+17.79% | 318B | |
+3.37% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.74% | 164B |
- Stock Market
- Equities
- 002728 Stock
- News Teyi Pharmaceutical Group Co.,Ltd
- Beijing Tongkanghui Network Technology Co., Ltd announced that it has received CNY 99.968 million in funding from Guangdong Temei Health Technology Industry Co., Ltd., Teyi Pharmaceutical Group Co.,Ltd